Cost-Effectiveness Analysis of Follow-Up Schedule for Hepatocellular Carcinoma after Radiofrequency Ablation

Figure 2

Forest plots of the study for each group. (a) The overall estimates of the 2-year recurrence-free survival (RFS) and the 95% confidence interval (CI) for HCC patients following radical radiofrequency ablation (RFA) in the 2- to 3-month group. (b) The overall estimates of the 2-y RFS and the 95% CI for HCC patients following radical RFA in the 3- to 4-month group.

(a)

(b)